Contrast agents for hepatic magnetic resonance imaging

Area of Science:

• Radiology and Medical Imaging
• Hepatology
• Oncology

Background:

• Accurate diagnosis of focal liver lesions (FLL) is crucial for patient management.
• Liver-specific contrast media (LSCM) offer enhanced visualization of FLL.
• Understanding lesion characteristics and contrast enhancement is key for differential diagnosis.

Purpose of the Study:

• To highlight the role of LSCM in the differential diagnosis of FLL.
• To explain the importance of understanding FLL biology and LSCM enhancement mechanisms.
• To demonstrate the utility of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in FLL characterization.

Main Methods:

• Classification of FLL into hypervascular, hypovascular, and delayed enhancement groups based on contrast kinetics.
• Utilizing dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for lesion identification and characterization.
• Correlating contrast enhancement patterns with the biologic and histologic findings of FLL.

Main Results:

• LSCM provides both dynamic (morphologic) and late-phase (functional) information.
• FLL can be accurately categorized based on contrast enhancement kinetics.
• High accuracy achieved in differentiating benign from malignant and hepatocellular from non-hepatocellular lesions using LSCM.

Conclusions:

• LSCM significantly improves the accuracy of FLL diagnosis.
• Knowledge of FLL biology and LSCM enhancement mechanisms is essential for precise characterization.
• DCE-MRI with LSCM is a valuable tool for differentiating FLL, guiding clinical decisions.